Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...
The Hacker News

OpenClaw AI Agent Flaws Could Enable Prompt Injection and Data Exfiltration

CNCERT warns OpenClaw AI agent has weak defaults enabling prompt injection and data leaks, prompting China to restrict use on ...
Nasdaq

China's First Domestic IL-23p19 Monoclonal Antibody: Innovent's PECONDLE® (Picankibart Injection) Received NMPA Approval

PECONDLE® (picankibart injection) has received approval from China's National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are ...
Morningstar

China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval

SAN FRANCISCO and SUZHOU, China, Dec. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Hosted on MSN

Sisram Medical clears key regulatory hurdle for DAXXIFY injection in mainland China

An update from Sisram Medical Ltd. ( (HK:1696)) is now available. Sisram Medical has announced that its sublicensed botulinum toxin type A injectable, DAXXIFY (DaxibotulinumtoxinA-lanm), for treating ...